UA75569C2 - Pharmaceutical composition of thiadiazolidinedione and method for its manufacture - Google Patents

Pharmaceutical composition of thiadiazolidinedione and method for its manufacture Download PDF

Info

Publication number: UA75569C2
Authority: UA; Ukraine
Prior art keywords: methyl; dihydro; oxo; dione; phenylmethyl
Prior art date: 1998-12-01

Application number

UA2001053674A

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Reddys Lab Ltd Dr

Reddys Lab Inc Dr

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-01

Filing date

1999-11-29

Publication date

2006-05-15

1999-11-29 Application filed by Reddys Lab Ltd Dr, Reddys Lab Inc Dr filed Critical Reddys Lab Ltd Dr

2006-05-15 Publication of UA75569C2 publication Critical patent/UA75569C2/uk

Links

239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 9
238000000034 method Methods 0.000 title claims description 7
238000004519 manufacturing process Methods 0.000 title description 7
PZWGPRQVKJVQSE-UHFFFAOYSA-N thiadiazolidine-4,5-dione Chemical group O=C1NNSC1=O PZWGPRQVKJVQSE-UHFFFAOYSA-N 0.000 title 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 11
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 24
239000000203 mixture Substances 0.000 claims description 20
150000003839 salts Chemical class 0.000 claims description 19
239000003826 tablet Substances 0.000 claims description 19
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 15
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 14
239000008101 lactose Substances 0.000 claims description 13
235000019359 magnesium stearate Nutrition 0.000 claims description 12
229920000168 Microcrystalline cellulose Polymers 0.000 claims description 9
-1 flavorings Substances 0.000 claims description 9
235000019813 microcrystalline cellulose Nutrition 0.000 claims description 9
239000008108 microcrystalline cellulose Substances 0.000 claims description 9
229940016286 microcrystalline cellulose Drugs 0.000 claims description 9
239000000454 talc Substances 0.000 claims description 9
229910052623 talc Inorganic materials 0.000 claims description 9
239000000843 powder Substances 0.000 claims description 8
238000003825 pressing Methods 0.000 claims description 4
239000002775 capsule Substances 0.000 claims description 3
235000003599 food sweetener Nutrition 0.000 claims description 3
239000000314 lubricant Substances 0.000 claims description 3
239000003765 sweetening agent Substances 0.000 claims description 3
230000015572 biosynthetic process Effects 0.000 claims description 2
239000000654 additive Substances 0.000 claims 1
230000000996 additive effect Effects 0.000 claims 1
239000003086 colorant Substances 0.000 claims 1
238000012876 topography Methods 0.000 claims 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract description 28
239000004480 active ingredient Substances 0.000 abstract description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 10
229960001375 lactose Drugs 0.000 description 10
239000003963 antioxidant agent Substances 0.000 description 9
235000006708 antioxidants Nutrition 0.000 description 9
239000000546 pharmaceutical excipient Substances 0.000 description 9
239000008187 granular material Substances 0.000 description 8
230000003078 antioxidant effect Effects 0.000 description 6
235000012222 talc Nutrition 0.000 description 6
229960001295 tocopherol Drugs 0.000 description 6
239000011732 tocopherol Substances 0.000 description 6
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 5
239000003085 diluting agent Substances 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
229930195725 Mannitol Natural products 0.000 description 4
ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 4
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
239000000594 mannitol Substances 0.000 description 4
235000010355 mannitol Nutrition 0.000 description 4
238000002156 mixing Methods 0.000 description 4
239000002552 dosage form Substances 0.000 description 3
239000008172 hydrogenated vegetable oil Substances 0.000 description 3
229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
235000010385 ascorbyl palmitate Nutrition 0.000 description 2
239000002585 base Substances 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
239000008112 carboxymethyl-cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
235000010980 cellulose Nutrition 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
230000037406 food intake Effects 0.000 description 2
238000005469 granulation Methods 0.000 description 2
230000003179 granulation Effects 0.000 description 2
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
235000010388 propyl gallate Nutrition 0.000 description 2
239000000473 propyl gallate Substances 0.000 description 2
229940075579 propyl gallate Drugs 0.000 description 2
239000012748 slip agent Substances 0.000 description 2
239000007909 solid dosage form Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000004408 titanium dioxide Substances 0.000 description 2
UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical class C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical class OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
108010011485 Aspartame Proteins 0.000 description 1
239000004322 Butylated hydroxytoluene Substances 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
229920002785 Croscarmellose sodium Polymers 0.000 description 1
229920000858 Cyclodextrin Polymers 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
RPWFJAMTCNSJKK-UHFFFAOYSA-N Dodecyl gallate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 RPWFJAMTCNSJKK-UHFFFAOYSA-N 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
229940122355 Insulin sensitizer Drugs 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
150000000994 L-ascorbates Chemical class 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
229920000881 Modified starch Polymers 0.000 description 1
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
150000001342 alkaline earth metals Chemical class 0.000 description 1
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
229960004977 anhydrous lactose Drugs 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
239000000605 aspartame Substances 0.000 description 1
235000010357 aspartame Nutrition 0.000 description 1
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
229960003438 aspartame Drugs 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
150000001558 benzoic acid derivatives Chemical class 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
150000001642 boronic acid derivatives Chemical class 0.000 description 1
235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
229940095259 butylated hydroxytoluene Drugs 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
150000001860 citric acid derivatives Chemical class 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
229960005168 croscarmellose Drugs 0.000 description 1
229960000913 crospovidone Drugs 0.000 description 1
239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
235000010386 dodecyl gallate Nutrition 0.000 description 1
239000000555 dodecyl gallate Substances 0.000 description 1
229940080643 dodecyl gallate Drugs 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000007580 dry-mixing Methods 0.000 description 1
239000000975 dye Substances 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
150000002315 glycerophosphates Chemical class 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
150000002688 maleic acid derivatives Chemical class 0.000 description 1
239000000463 material Substances 0.000 description 1
238000007909 melt granulation Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
ODLHGICHYURWBS-FOSILIAISA-N molport-023-220-444 Chemical compound CC(O)COC[C@@H]([C@@H]([C@H]([C@@H]1O)O)O[C@@H]2O[C@H]([C@H](O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O3)[C@@H](O)[C@@H]2O)COCC(O)C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@H]3O[C@H]1COCC(C)O ODLHGICHYURWBS-FOSILIAISA-N 0.000 description 1
150000002823 nitrates Chemical class 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
235000010387 octyl gallate Nutrition 0.000 description 1
239000000574 octyl gallate Substances 0.000 description 1
NRPKURNSADTHLJ-UHFFFAOYSA-N octyl gallate Chemical compound CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 NRPKURNSADTHLJ-UHFFFAOYSA-N 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
238000005498 polishing Methods 0.000 description 1
235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229940069328 povidone Drugs 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
239000008213 purified water Substances 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
150000003873 salicylate salts Chemical class 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
150000003900 succinic acid esters Chemical class 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
150000003892 tartrate salts Chemical class 0.000 description 1
235000010384 tocopherol Nutrition 0.000 description 1
229930003799 tocopherol Natural products 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
239000012178 vegetable wax Substances 0.000 description 1
238000005550 wet granulation Methods 0.000 description 1
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

UA2001053674A 1998-12-01 1999-11-29 Pharmaceutical composition of thiadiazolidinedione and method for its manufacture UA75569C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA199801580		1998-12-01
PCT/DK1999/000663 WO2000032191A1 (en)	1998-12-01	1999-11-29	New pharmaceutical composition and the process for its preparation

Publications (1)

Publication Number	Publication Date
UA75569C2 true UA75569C2 (en)	2006-05-15

Family

ID=8106261

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA2001053674A UA75569C2 (en)	1998-12-01	1999-11-29	Pharmaceutical composition of thiadiazolidinedione and method for its manufacture

Country Status (21)

Country	Link
US (1)	US7439248B1 (de)
EP (1)	EP1135127B1 (de)
JP (2)	JP5524435B2 (de)
KR (1)	KR100690311B1 (de)
CN (1)	CN1158075C (de)
AT (1)	ATE316376T1 (de)
AU (1)	AU776299B2 (de)
BR (1)	BR9915835A (de)
CA (1)	CA2352430C (de)
CZ (1)	CZ300543B6 (de)
DE (1)	DE69929635T2 (de)
ES (1)	ES2257886T3 (de)
HU (1)	HUP0104544A3 (de)
IL (3)	IL143299A0 (de)
NO (1)	NO329909B1 (de)
PL (1)	PL197077B1 (de)
RU (1)	RU2233659C2 (de)
TW (1)	TWI235657B (de)
UA (1)	UA75569C2 (de)
WO (1)	WO2000032191A1 (de)
ZA (1)	ZA200104261B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA75569C2 (en) *	1998-12-01	2006-05-15	Reddys Lab Ltd Dr	Pharmaceutical composition of thiadiazolidinedione and method for its manufacture
US20010047032A1 (en) *	1999-12-30	2001-11-29	Castillo Gerardo M.	Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
AU2001260083A1 (en)	2000-05-26	2001-12-03	Dr. Reddy's Research Foundation	New pharmaceutical composition and the process for its preparation
WO2001091751A1 (en) *	2000-05-30	2001-12-06	Novo Nordisk A/S	New pharmaceutical composition and the process for its preparation
US20050118202A1 (en) *	2001-12-19	2005-06-02	Akio Yamashita	Solid compositions containing compounds unstable to oxygen and method for stabilization thereof
EP1634908B1 (de) *	2003-05-30	2017-01-11	Asahi Kasei Kabushiki Kaisha	Cellulosepulver
WO2006002255A2 (en) *	2004-06-23	2006-01-05	Dr. Reddy's Laboratories Ltd.	A pharmaceutical formulation of balaglitazone
CL2008000596A1 (es) *	2007-03-01	2008-09-05	Glaxo Group Ltd	Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4280997A (en) *	1978-12-08	1981-07-28	Johannes Van Leverink	Extrusion process for the preparation of anhydrous stable lactose
DE3433239A1 (de) *	1984-09-11	1986-03-20	Bayer Ag, 5090 Leverkusen	Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
US5330998A (en) *	1988-03-08	1994-07-19	Pfizer Inc.	Thiazolidinedione derivatives as hypoglycemic agents
CA2019324C (en) *	1989-07-10	1996-08-20	Robert L. Jerzewski	Fosinopril tablet formulations
FR2656610B1 (fr) *	1989-12-29	1992-05-07	Sanofi Sa	Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
IT1238072B (it) *	1990-01-19	1993-07-03	Sclavo Spa	Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
CZ225893A3 (en) *	1991-04-04	1994-04-13	Procter & Gamble	Chewing antacid preparation
CZ227093A3 (en) *	1991-04-29	1994-03-16	Merck & Co Inc	Mixture suitable for the preparation of tablets by direct moulding
TW245716B (de) *	1992-12-28	1995-04-21	Takeda Pharm Industry Co
TW268952B (de) *	1993-02-26	1996-01-21	Takeda Pharm Industry Co Ltd
HU224548B1 (hu) *	1993-04-07	2005-10-28	Taiho Pharmaceutical Co. Ltd.	Tiazolidinszármazékok és ezeket tartalmazó gyógyszerkészítmények, valamint eljárás előállításukra
ES2185666T3 (es) *	1993-09-03	2003-05-01	Smithkline Beecham Corp	Formulacion estabilizada para comprimidos.
US5457109A (en) *	1993-09-15	1995-10-10	Warner-Lambert Company	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5532256A (en)	1994-05-18	1996-07-02	American Home Products Corporation	New azolidinediones and thiadiazolidinediones as antihyperglycemic agents
ES2079327B1 (es) *	1994-12-13	1996-08-01	Lilly Sa	Formulaciones farmaceuticas de cefaclor.
PT800384E (pt) *	1994-12-14	2001-06-29	Enbalt Trading Ltd	Metodo para a preparacao de um comprimido farmaceutico
US6395303B1 (en) *	1996-06-10	2002-05-28	Edward Mendell Co., Inc.	Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
JPH09249561A (ja) *	1996-03-15	1997-09-22	Teikoku Chem Ind Corp Ltd	医薬組成物
WO1997041097A2 (en) *	1996-12-31	1997-11-06	Dr. Reddy's Research Foundation	Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
HU222109B1 (hu) *	1996-09-10	2003-04-28	EGIS Gyógyszergyár Rt.	Captopriltartalmú tabletták és eljárás ezek előállítására
ATE269862T1 (de)	1997-12-02	2004-07-15	Reddys Lab Ltd Dr	Substituierte thiazolidinedione und oxazolidinedione mit antidiabetischen, hypolipidämischen und antihypertensiven eigenschaften
EP0945134A1 (de) *	1998-03-27	1999-09-29	Boehringer Ingelheim Pharma KG	Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
UA75569C2 (en) *	1998-12-01	2006-05-15	Reddys Lab Ltd Dr	Pharmaceutical composition of thiadiazolidinedione and method for its manufacture
AU2001260083A1 (en) *	2000-05-26	2001-12-03	Dr. Reddy's Research Foundation	New pharmaceutical composition and the process for its preparation
WO2006002255A2 (en)	2004-06-23	2006-01-05	Dr. Reddy's Laboratories Ltd.	A pharmaceutical formulation of balaglitazone

1999
- 1999-11-29 UA UA2001053674A patent/UA75569C2/uk unknown
- 1999-11-29 AT AT99972919T patent/ATE316376T1/de not_active IP Right Cessation
- 1999-11-29 RU RU2001117850/15A patent/RU2233659C2/ru not_active IP Right Cessation
- 1999-11-29 CZ CZ20011832A patent/CZ300543B6/cs not_active IP Right Cessation
- 1999-11-29 EP EP99972919A patent/EP1135127B1/de not_active Expired - Lifetime
- 1999-11-29 IL IL14329999A patent/IL143299A0/xx active IP Right Grant
- 1999-11-29 DE DE69929635T patent/DE69929635T2/de not_active Expired - Lifetime
- 1999-11-29 CA CA002352430A patent/CA2352430C/en not_active Expired - Fee Related
- 1999-11-29 JP JP2000584886A patent/JP5524435B2/ja not_active Expired - Fee Related
- 1999-11-29 ES ES99972919T patent/ES2257886T3/es not_active Expired - Lifetime
- 1999-11-29 HU HU0104544A patent/HUP0104544A3/hu unknown
- 1999-11-29 BR BR9915835-3A patent/BR9915835A/pt not_active Application Discontinuation
- 1999-11-29 AU AU13762/00A patent/AU776299B2/en not_active Ceased
- 1999-11-29 WO PCT/DK1999/000663 patent/WO2000032191A1/en not_active Ceased
- 1999-11-29 KR KR1020017006782A patent/KR100690311B1/ko not_active Expired - Fee Related
- 1999-11-29 PL PL348601A patent/PL197077B1/pl unknown
- 1999-11-29 CN CNB99813970XA patent/CN1158075C/zh not_active Expired - Fee Related
- 1999-11-30 US US09/450,609 patent/US7439248B1/en not_active Expired - Fee Related
- 1999-12-27 TW TW088123261A patent/TWI235657B/zh not_active IP Right Cessation
2001
- 2001-05-22 IL IL143299A patent/IL143299A/en not_active IP Right Cessation
- 2001-05-24 ZA ZA200104261A patent/ZA200104261B/en unknown
- 2001-05-31 NO NO20012673A patent/NO329909B1/no not_active IP Right Cessation
2006
- 2006-12-05 IL IL179865A patent/IL179865A/en not_active IP Right Cessation
2012
- 2012-04-06 JP JP2012087678A patent/JP2012144560A/ja active Pending

Also Published As

Publication number	Publication date
WO2000032191A1 (en)	2000-06-08
NO20012673L (no)	2001-05-31
PL197077B1 (pl)	2008-02-29
JP2002531404A (ja)	2002-09-24
DE69929635D1 (de)	2006-04-13
JP5524435B2 (ja)	2014-06-18
IL179865A (en)	2009-12-24
IL143299A0 (en)	2002-04-21
CZ300543B6 (cs)	2009-06-10
US7439248B1 (en)	2008-10-21
CA2352430A1 (en)	2000-06-08
IL179865A0 (en)	2007-05-15
EP1135127B1 (de)	2006-01-25
EP1135127A1 (de)	2001-09-26
TWI235657B (en)	2005-07-11
HUP0104544A2 (en)	2002-08-28
RU2233659C2 (ru)	2004-08-10
BR9915835A (pt)	2001-08-21
IL143299A (en)	2006-12-31
HUP0104544A3 (en)	2003-12-29
CA2352430C (en)	2008-11-18
KR100690311B1 (ko)	2007-03-09
CN1356901A (zh)	2002-07-03
ATE316376T1 (de)	2006-02-15
AU1376200A (en)	2000-06-19
NO20012673D0 (no)	2001-05-31
CN1158075C (zh)	2004-07-21
AU776299B2 (en)	2004-09-02
ES2257886T3 (es)	2006-08-01
PL348601A1 (en)	2002-06-03
CZ20011832A3 (cs)	2001-10-17
DE69929635T2 (de)	2006-09-21
KR20010099827A (ko)	2001-11-09
JP2012144560A (ja)	2012-08-02
ZA200104261B (en)	2002-05-24
NO329909B1 (no)	2011-01-24

Publication	Publication Date	Title
KR100477293B1 (ko)	2005-03-17	플래쉬-용융 경구 투여 제형
FI117373B (fi)	2006-09-29	Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
JP5798641B2 (ja)	2015-10-21	経口投与用医薬組成物
JP2012144560A (ja)	2012-08-02	新規医薬組成物及びその調製のための方法
WO2003086361A1 (en)	2003-10-23	Rapidly dispersing solid oral compositions
US20010046990A1 (en)	2001-11-29	Pharmaceutical composition and the process for its preparation
US6710050B2 (en)	2004-03-23	Pharmaceutical composition and the process for its preparation
WO2005123041A1 (en)	2005-12-29	Oral dispersible tablet composition of amoxycillin and/or clavulanic acid comprising a surface-modified sodium bicarbonate
WO2001091751A1 (en)	2001-12-06	New pharmaceutical composition and the process for its preparation
MXPA01005420A (en)	2002-05-09	New pharmaceutical composition and the process for its preparation
KR20110105550A (ko)	2011-09-27	에카베트 또는 그의 염을 함유하는 경구용 정제